Covid-19 Continent-wide Antibodies Research begins in Africa

Covid-19 Continent-wide Antibodies Research begins in Africa

Last updated on September 11th, 2021 at 08:39 am

Large Continent and Low Numbers

Africa hit 1 million tested covid-19 instances last week and as some experts are eager to ascertain the actual demonstrated case facts and comprehend the obvious extraordinarily low caseload – with just beneath 800,000 recoveries and much less than only 25,000 fatalities on the continent of 1.3 billion people, others are interested in the findings that point out a presence of antibodies to the virus in some Africans – 1 in 20 people in Kenya and 2-5% of households in two cities in Mozambique, in accordance to research.

A continent-wide antibodies case study is underway as announced Thursday by using the Africa Centers for Disease Control and Prevention. Around 7 international locations – specifically Liberia, Sierra Leone, Zambia, Zimbabwe, Cameroon, Nigeria and Morocco, have already expressed activity in engaging in the study – which will encompass the entire continent.

Study things to do with the aforementioned international locations should start as early as subsequent week.